• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

10

CATEGORIES

  • 6
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

1
3
9
20

PUBLISHED

0
2
3
20

PRODUCT TYPE

18
2

Search "LEO Pharma A/S-Therapeutic Competitors Report" returned 20 results.

PRODUCT TITLE

Hyperparathyroidism Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Hyperparathyroidism Therapeutics - Pipeline Assessment and Market Forecasts to 2017 Summary GlobalData, the industry analysis specialist, has released its new report, “Hyperparathyroidism Therapeutics...

December 2011
FROM
IMS Company Profiles:Leo Pharma IMS Company Profiles:Leo Pharma - Product Thumbnail Image

IMS Company Profiles:Leo Pharma

IMS Company Profiles gives a clear picture of the companies' strengths in terms of therapy areas and relevant marketed products as well as the future strategic direction of companies including R&D pipelines,...

July 2013

Bone and Joint Infection Market to 2016 - Medical Imaging and PCR Methods to Facilitate Early Diagnosis and Treatment

Bone and Joint Infection Market to 2016 - Medical Imaging and PCR Methods to Facilitate Early Diagnosis and Treatment Summary GBI Research, the leading business intelligence provider, has released its...

February 2011
FROM
Commercializing Breast Cancer Drugs: The Faster Route to Consider Your Options and Position of Others Commercializing Breast Cancer Drugs: The Faster Route to Consider Your Options and Position of Others - Product Thumbnail Image

Commercializing Breast Cancer Drugs: The Faster Route to Consider Your Options and Position of Others

This report will excel your competitive awareness and decrease your decision making time in managing breast cancer drug development Find out whether you are number one, two or further down the ladder...

August 2012
FROM
Commercializing Pancreatic Cancer Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others Commercializing Pancreatic Cancer Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others - Product Thumbnail Image

Commercializing Pancreatic Cancer Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others

This report will excel your competitive awareness and decrease your decision making time in managing pancreatic cancer drug development Find out whether you are number one, two or further down the ladder...

March 2012
FROM
A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market - Product Thumbnail Image

A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market

This report comprises defined and up to date development strategies for 347 colorectal cancer drugs within the portfolio of 182 companies, from Ceased to Marketed The report extensively analyses their...

March 2011
FROM
A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market - Product Thumbnail Image

A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market

This report comprises defined and up to date development strategies for 282 lymphoma drugs within the portfolio of 152 companies, from Ceased to Marketed The report extensively analyses their 181 identified...

May 2011
FROM
Competitive Insights to Protein Kinase Therapeutics in Oncology: The Faster Route to Consider Your Options and Position of Others Competitive Insights to Protein Kinase Therapeutics in Oncology: The Faster Route to Consider Your Options and Position of Others - Product Thumbnail Image

Competitive Insights to Protein Kinase Therapeutics in Oncology: The Faster Route to Consider Your Options and Position of Others

This report represents a new and unique way of stratifying and analyzing the global protein kinase drug pipeline in oncology towards personalized medicine It will excel your competitive awareness and...

May 2012
FROM

Galderma Patent Survey 2013

Galderma S.A. is a leading pharmaceutical company focused exclusively on dermatology. It provides therapeutic and aesthetic solutions for the treatment of major skin diseases such as acne, pigmentary...

January 2013
FROM
Commercializing Apoptotic Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others Commercializing Apoptotic Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others - Product Thumbnail Image

Commercializing Apoptotic Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others

This report will excel your competitive awareness and decrease your decision making time in managing apoptotic drug development in cancer Find out whether you are number one, two or further down the...

December 2011
A Decision Support Tool for Optimizing The Leukemia Pipeline: From Research and Development to Market A Decision Support Tool for Optimizing The Leukemia Pipeline: From Research and Development to Market - Product Thumbnail Image

A Decision Support Tool for Optimizing The Leukemia Pipeline: From Research and Development to Market

This report comprises defined and up to date development strategies for 313 leukemia drugs within the portfolio of 186 companies, from Ceased to Marketed. The report extensively analyses their 204 identified...

April 2011
FROM

Actinic (Solar) Keratosis - Pipeline Review, H1 2014

Actinic (Solar) Keratosis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Actinic (Solar) Keratosis - Pipeline Review, H1 2014’, provides an overview of the Actinic (Solar) Keratosis’s...

March 2014
FROM
MRSA Drug Futures MRSA Drug Futures - Product Thumbnail Image

MRSA Drug Futures

MRSA: a complex issue MRSA infection - especially the hospital acquired variety - has been front page news for some years, but reports of falling rates of infection in the US and Europe masks the real...

September 2010
FROM

Psoriasis - Pipeline Review, H1 2014

Psoriasis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Psoriasis - Pipeline Review, H1 2014’, provides an overview of the Psoriasis’s therapeutic pipeline. This report provides comprehensive...

February 2014
FROM

Kidney Disease - Pipeline Review, H1 2014

Kidney Disease - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Kidney Disease - Pipeline Review, H1 2014’, provides an overview of the Kidney Disease’s therapeutic pipeline. This report...

March 2014
FROM

Actinic (Solar) Keratosis - Pipeline Review, H2 2014

Actinic (Solar) Keratosis - Pipeline Review, H2 2014 Summary This, ‘Actinic (Solar) Keratosis - Pipeline Review, H2 2014’, provides an overview of the Actinic (Solar) Keratosis’s therapeutic pipeline. This...

August 2014
FROM

Galderma S.A. - Strategic SWOT Analysis Review

Galderma S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT...

January 2015
FROM

Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth

“Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth” The systemic psoriasis market is forecast to grow substantially...

February 2014
FROM

Human Papillomavirus Infections - Pipeline Review, H1 2015

Human Papillomavirus Infections - Pipeline Review, H1 2015 Summary This, ‘Human Papillomavirus Infections - Pipeline Review, H1 2015’, provides an overview of the Human Papillomavirus Infections’s...

March 2015
FROM

PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2022 Summary There are no long-term effective therapies for Psoriasis (PsO), so this remains at the top of the list for unmet needs....

May 2013
FROM
Loading Indicator

Our Clients

Goodyear Tire & Rubber Company GlaxoSmithKline PLC Hilton Worldwide Hewlett-Packard Company Accenture PLC. Qualcomm Incorporated UBS AG